OrthoSpineNews

JUNE 18, 2025

BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , I am excited to be working with ReGelTec and the other principal investigators to enroll the HYDRAFIL-D Study and evaluate the impact of HYDRAFIL on patients with degenerative disc disease.” Walnut Creek, Calif.; Greenwood Village, Colo.; Jasper, Ga.;

Degenerative Disc Disease

OrthoSpineNews

JUNE 23, 2025

June 23, 2025 /PRNewswire/ — Cerapedics Inc., Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

Degenerative Disc Disease

OrthoSpineNews

JULY 8, 2025

July 8, 2025 /PRNewswire/ — Cerapedics Inc., The first post-approval procedure on an adult patient with degenerative disc disease (DDD) was performed by neurosurgeon Sharad Rajpal, M.D., The fusion is achieved using a bone graft, which, over time, helps the vertebrae grow together to form one continuous bone.

Degenerative Disc Disease

OrthoSpineNews

FEBRUARY 10, 2025

10, 2025/PRNewswire/ — Report on how AI is redefining market landscape – The global spinal implants market size is estimated to grow byUSD 3.55 billionfrom 2025-2029, according to Technavio. Market growth 2025-2029 USD 3554.5 NEW YORK,Feb. The market is estimated to grow at a CAGR of almost5.3% JAYON IMPLANTS Pvt.

Degenerative Disc Disease